Hussein A. Tawbi
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Scripps MD Anderson Cancer Center(US)Research Network (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Melanoma and MAPK Pathways, Immune cells in cancer
Most-Cited Works
- → Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients(2017)4,526 cited
- → B cells are associated with survival and immunotherapy response in sarcoma(2020)1,847 cited
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain(2018)1,297 cited
- → Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance(2017)908 cited
- → Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial(2012)901 cited